Because Treatable Should Mean Insurable
We provide life insurance for people living with chronic but manageable conditions—using modern science, not outdated assumptions.
The future of life insurance is inclusive, evidence-based, and grounded in dignity.
We exist to make sure people living with HIV, leukemia, Hodgkin’s lymphoma, and other chronic but treatable conditions can protect their families just like anyone else.
For too long, life insurance has shut out people who are under care, stable on treatment, and thriving. Traditional underwriting labels them as “uninsurable,” relying on outdated mortality assumptions instead of modern medicine.
At Kibou, we’re changing that.
We use real-world clinical data, actuarial rigor, and tech-enabled underwriting to open up access, starting with a few conditions, and expanding as we grow. Our goal is simple but bold: make life insurance fair and accessible for people who’ve been unfairly excluded.
Kibou means “hope” in Japanese. We’re here to bring hope, and coverage, to the millions who’ve been told no.
Our Mission
Over 30 million Americans live with treatable chronic conditions—yet most are denied life insurance coverage.
Who We Cover Today
Chronic Myeloid Leukemia (CML)
Thanks to daily targeted therapy (TKIs), many CML patients now live near-normal lifespans. We underwrite applicants in chronic phase, on treatment, and in molecular remission.
HIV+
With sustained ART adherence and viral suppression, modern HIV+ adults can live long, healthy lives. We evaluate risk based on CD4 count, viral load, adherence, and comorbidities.
Hodgkin Lymphoma (HL)
For long-term survivors in remission, especially those treated at early stages, risk diminishes over time. We use remission-adjusted mortality modeling to offer fair access to coverage.
Let’s Build This Together
We’re building something new: life insurance that finally sees you.
If you or someone you love has been denied coverage due to a chronic but treatable condition, we’d love to hear from you. Your story can help shape a better path forward.